FBRX
Forte Biosciences Inc
77.00$
+0.0%
vs. previous close
Closing price · As of: Aug 28, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | +0.0% | +0.0% | +0.0% | +0.0% | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | -100.0% | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -7.1% | -30.8% | – | – | – | – | – | – | – | – | +100.0% | +50.0% | +11.1% | +0.0% | +0.0% | +30.0% | +15.4% | +13.3% | -364.7% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -142.2% | – | – | |
| – | +0.1% | +14.0% | +9.7% | +25.8% | +22.3% | -3.9% | +27.4% | -94.5% | -64.1% | +13.9% | +2,051.8% | -82.2% | +43.1% | +90.4% | -18.0% | +9.8% | +6.1% | +60.3% | -76.1% | -48.7% | +49.2% | +33.4% | +80.4% | +92.4% | +49.1% | -10.8% | -44.0% | +22.0% | +31.9% | -0.3% | -8.6% | +139.8% | -31.3% | +74.6% | +42.4% | -5.2% | -99.3% | – | |
| – | +4.6% | +7.6% | +10.0% | +0.7% | +6.4% | +67.9% | -19.1% | -90.7% | -1.5% | +3.8% | +841.1% | -78.4% | +12.9% | +73.7% | +11.2% | -3.3% | +56.7% | -8.1% | -4.7% | -6.5% | +9.1% | +2.9% | +19.9% | -15.6% | -8.4% | +103.0% | -26.9% | +22.6% | +105.1% | -61.0% | -23.1% | +61.8% | -13.8% | +7.5% | -10.9% | -30.5% | +15.1% | – | |
| – | +1.1% | +12.5% | +9.7% | +20.2% | +19.3% | +8.1% | +15.3% | -93.8% | -46.9% | +8.7% | +1,255.6% | -78.1% | +1,614.6% | -85.6% | -10.3% | +5.5% | +21.2% | +33.8% | -57.1% | -23.8% | +20.1% | +13.3% | +44.3% | +38.8% | +31.8% | +13.1% | -37.6% | +22.3% | +64.3% | -32.7% | -14.8% | +119.5% | -28.2% | +58.8% | +34.0% | -8.8% | +9.6% | – | |
| – | – | – | – | – | – | – | -1,439.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -19.6% | -13.1% | -9.1% | -10.7% | +213.2% | -32.1% | +1.5% | -71.7% | +258.7% | +158.2% | -93.3% | +468.4% | – | – | – | – | – | – | – | +26.2% | -71.7% | +53.3% | -73.9% | +1,600.0% | – | – | – | +0.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -1,824.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | +112.6% | -113.3% | – | – | – | +0.0% | +3,205,600.0% | – | – | – | – | – | – | +26.2% | -71.7% | -253.3% | – | -1,800.0% | – | – | – | -130.1% | – | – | – | – | – | – | – | -64.0% | -48.3% | – | |
| – | – | – | – | – | – | – | -958.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -978.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -7,311.6% | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.